Kinetic characterization of human immunodeficiency virus type 1 protease: determination of inhibitor rate constants

M M Morelock1, E T Graham, D Erdman

  • 1Section of Biophysics, Department of Inflammatory Diseases, Boehringer Ingelheim Pharmaceuticals, Inc., Research and Development Center, Ridgefield, Connecticut 06877-0368, USA.